Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

VentriPoint Diagnostics Ltd V.VPT

Alternate Symbol(s):  VPTDF

Healthcare Medical Devices
Ventripoint Diagnostics Ltd is a Canada-based medical device company. The Company is engaged in the development and commercialization of diagnostic tools that monitor patients with heart disease. It is developing a suite of applications for all heart diseases and imaging modalities, including congenital heart disease, pregnancy, pulmonary hypertension, COVID-19, imaging, and cardiotoxicity in oncology patients. The Company’s Ventripoint Medical System (VMS+) is a diagnostic aid that was developed to provide a point-of-care solution to better communicate the heart’s structure and function without the need for magnetic resonance imaging (MRI). VMS+ enhances ultrasound, providing three-dimensional (3D) technology that allows for visualization of all four chambers of the heart. The system’s proprietary Knowledge Based Reconstruction (KBR) technology creates 3D models of the heart and calculates volumes and ejection fractions equivalent to the gold-standard Magnetic resonance imaging (MRI).


TSXV:VPT - Post by User

VentriPoint Diagnostics Ltd > Pandora
<< Previous
 Bullboard Posts
Next >>
User Avatar Image
(1564)
•••
Comment by Pandoraon Oct 28, 2022 7:37pm
70 Views
Post# 35057190

RE:RE:RE:Pandora

RE:RE:RE:Pandora
theNorm wrote:
you are hilarious pandora, you say no solid evidence of GEHC Edison association? What about the Ventripoint icon centre left on the GEHC site? What a smuck. What a maroon (bugs bunny language for a family audience) You are not worth the time to show as a liar about revenues. You are dismissed as a stockhouse bashing putz buddy.


Classy -- so you're saying the logo on the GEHC webpage is evidence of a signed deal valued at ??? and it has no effect on the share price? Or is the "partnership" actually valued at some portion of 30 cents in your eyes?

And you're telling me the numbers in the financials, as posted in Sedar, are lies? Great.

I guess I can bow out of these two conversations at this point -- enough for one day, or one year.
<< Previous
 Bullboard Posts
Next >>
Dealroom for high-potential pre-IPO opportunities